European Archives - Page 311 of 1349 - European Medical Journal

Advancing Immunotherapy for Keratinocyte Carcinoma Prevention

Immune checkpoint inhibitors represent an exciting avenue for managing field cancerisation and reducing the keratinocyte carcinoma burden.

Combination Therapy with Glutathione Shows Promise in Hepatitis B Treatment

A randomised controlled trial showed that adding reduced glutathione to entecavir therapy can significantly improve liver function, reduce fibrosis, and enhance HBV-DNA clearance in chronic hepatitis B patients.

Adults with Depression Develop Physical Illnesses 30% Faster

New research finds adults with depression develop physical illnesses 30% faster. Integrated care approaches are urgently needed.

Rheumatoid Arthritis Tied to Elevated Kidney Cancer Risk

A study from South Korea reveals that rheumatoid arthritis (RA) significantly increases the risk of kidney cancer, particularly among women. Despite the lack of association with bladder, prostate, and testicular cancers, the findings stress the importance of early detection in RA patients.

Global Infertility Rates Rising, Study Finds

A new study analysing global infertility trends from 1990 to 2021 reveals a sharp rise in cases, with projections showing continued increases until 2036. India, China, and Indonesia report the highest infertility rates, highlighting an urgent need for improved healthcare access and fertility treatment strategies.

Single-Cell Study Reveals Ageing Reprogrammes Breast Tissue Boosting Cancer Risk

New research reveals how aging rewires mammary gland cells, increasing breast cancer risk through epigenetic and immune changes.

New Oral Regimens Shorten Rifampin-Resistant Tuberculosis Treatment

New 9-month, all-oral regimens for fluoroquinolone-susceptible, rifampin-resistant tuberculosis are as effective as the standard longer-duration therapy.

Breakthrough Blood Test Offers Hope for Early Pancreatic Cancer Detection

A new blood test, PAC-MANN, shows promise for early detection of pancreatic cancer, improving treatment options and survival rates.

A New Way to Improve Melanoma Immunotherapy

Leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Degenerative Mitral Regurgitation: 10-Year Study Confirms High Survival Rates with Surgical Repair

A decade-long study confirms excellent survival and low reoperation rates for mitral valve repair at high-volume centres.